ALHC Stock Analysis: Buy, Sell, or Hold?
ALHC - Alignment Healthcare, Inc. Common Stock
$13.16
0.23 (1.78%)
▲
5d:
-5.73%
30d:
-34.2%
90d:
-19.61%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When ALHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ALHC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ALHC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.63
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.75
42.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALHC is currently trading at $13.16, which is considered oversold relative to its 30-day fair value range of $13.30 to $19.89. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.5) compared to its historical average (33.9). Remarkably, the market is currently pricing in an annual earnings decline of 19.8% over the next few years. This pessimistic expectation contrasts with the company's recent 142.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ALHC is in a downtrend. Immediate support is located at $12.70, while resistance sits at $14.31.
Market Sentiment: ALHC scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $24.08 (+83.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALHC is in a downtrend. Immediate support is located at $12.70, while resistance sits at $14.31.
Market Sentiment: ALHC scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $24.08 (+83.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$13.30 -
$19.89
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding ALHC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.0% below Wall St target ($24.08)
- CAUTION: Bottoming setup, but lagging the sector by 32% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-5.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$13.30 -
$19.89
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$12.70
Resistance Level
$14.31
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.49
Wall Street Target
$24.08
(+83.0%)
Revenue Growth (YoY)
31.6%
Earnings Growth (YoY)
142.9%
Profit Margin
0.9%
Valuation Discount vs History
-19.8% cheaper
PE vs Historical
17.5 vs 33.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.8%
(market-implied from PE analysis)
1-Year Target
$11.84
(-10%)
2-Year Target
$10.66
(-19%)
3-Year Target
$9.59
(-27%)
3-Yr Target (if PE normalizes)
(PE: 17→34)
$18.60
(+41%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 52.0%)
$50.97
(+287%)
Base:
(SPY PE: 17.5, Growth: 52.0%)
$44.42
(+238%)
Bear:
(PE: 14.9, Growth: 52.0%)
$37.75
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (68x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 68.05 | Current EPS (TTM): $0.19
Bull Case
$28.45
(+116%)
Analyst growth 100.0%, PE expands to 74.9
Base Case
$25.86
(+97%)
Market implied 100.0%, PE stable at 68.1
Bear Case
$8.79
(-33%)
Severe decline -20.0%, PE contracts to 57.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.5 to 33.9
Stabilization Target:
$25.51
(+93.8%)
PE Expansion Potential:
+93.8%
Share & Embed Analysis
Last updated: August 22, 2026 7:08 PM ET
Data refreshes hourly during market hours. Next update: 8:08 PM
Data refreshes hourly during market hours. Next update: 8:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Dawn Christine Maroney
SELL
30000 shares
2026-04-15
John E Kao
SELL
82299 shares
2026-04-13
John E Kao
SELL
215701 shares
2026-04-10
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 65 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 50 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 48 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 54 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$416 | 60 BUY |
Advanced ALHC Option Strategies
Professional options setups generated by AI based on today's ALHC price and gamma walls.
